Navigation Links
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform
Date:10/1/2013

he 645 patients included in this study, 69% were <65 years old, 61% were males, and median brain Abbreviated Injury Score (AIS) was 3. There were 11 deaths and 56 patients were discharged to a skilled nursing facility. After adjustment in a multivariate logistic regression model, a 20mV increase in the first ORP measurement (obtained within 48 hours of admission) was associated with a 4-fold odds increase of in-hospital mortality (OR: 4.24, 95%CI: 1.2-15.3) and 1.3-fold odds increase of being discharged to a SNF (OR: 1.28, 95%CI: 1.00-1.63).  Likewise, decrease in antioxidant reserves, as measured by last inverse Capacity (1/cORP) were associated with significant patients outcomes. For example a 1 unit increase in the last inverse cORP was associated with a 5-fold odds increase in hospital mortality (OR: 5.05, 95%CI 1.2-21.3). Detailed results from this study will be presented at an upcoming scientific meeting. 

Luoxis' Chief Scientific Officer David Bar-Or, MD, commented "this recent analysis in traumatic brain injury demonstrates again how oxidation-reduction potential and antioxidant reserves serve as important markers of injury in this significant condition.  By having a novel measure like ORP available for rapid analysis of oxidative stress and antioxidant reserves, we can enable better clinical insights into these traumatic brain injury patients and potentially improve clinical management based on their condition's severity and ORP measures."

Traumatic brain injury affects at least 1.7 million patients in the US alone each year, and the incidence is highest among patients 75 years of age and older.  Luoxis Diagnostics is studying specific conditions where oxidative stress is implicated, and the company has a distinct focus on critical illness, injury, and frailty among the elderly population.  Additional studies are ongoing to assess oxidation-reduction potential in multiple conditions, and the RedoxSYS diagnostic sys
'/>"/>

SOURCE Luoxis Diagnostics; Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
2. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
3. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
4. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
5. Levine Leichtman Acquires Champion Manufacturing
6. Pro Athletes Team Up to Champion Gout Awareness
7. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
8. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
9. Ampio Pharmaceuticals to List on the NYSE MKT
10. Ampio Pharmaceuticals Provides Clinical Updates
11. Synergy Health Wins Practice Green Health Champion for Change Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014  Dyadic International, ... with patented and proprietary technology used to develop ... bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, ... payment from Abengoa Bioenergy for commercial scale production ... biomass into ethanol, developed under Abengoa,s license agreement ...
(Date:10/1/2014)... NEW YORK , October 1, 2014 ... provider for the medical industries, announced today the expansion of its ... New York City . genae Americas was incorporated in 2011. ... centered in one of the highest concentrations of medical innovation and ... , President at genae Americas. "The expansion of genae from ...
(Date:10/1/2014)... Oct. 1, 2014  Varian Medical Systems (NYSE: ... results for the fourth quarter of fiscal year 2014 ... 22, 2014.  The news release will be followed by ... p.m. PT.  The news release and a link to ... company website at: www.varian.com/investor .  To access the ...
Breaking Medicine Technology:Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3genae Opens Offices in New York City 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
... As part of its ongoing work in the prevention ... Diagnostics is pleased to announce its sponsorship of the ... a kick-off event at Loyola University in Chicago on ... the goal of World MRSA Day is to highlight ...
... 28 Chimerix, Inc., a pharmaceutical company developing orally-available ... and Chief Executive Officer, will present a corporate overview ... 5th, 2010 at 2:00pm PT.  The conference is being ... Mr. Moch will discuss the company,s antiviral ...
Cached Medicine Technology:Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 2Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 3Chimerix to Present at 9th Annual BIO Investor Forum 2
(Date:10/1/2014)... study published today in the Journal of the ... than 50 years with moderate or severe chronic knee ... from the University of Melbourne randomly assigned 282 patients ... no acupuncture or sham or pretend laser treatment. ... and acupuncturists blinded to laser and sham (inactive) laser ...
(Date:10/1/2014)... 1, 2014) Despite a policy focus on ... disabilities, this vulnerable population continues to have significant ... The Journal of the American Dental Association , ... Tufts University School of Dental Medicine report on ... at-home oral care provided by caregivers to adults ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog post explaining how ... family members. , Life insurance plans provide important financial ... should always carry a life insurance policy as their ... the family. , Clients can choose from several ... coverage or from a permanent policy. No medical exam ...
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... business worldwide. This rapid growth includes increased hiring for ... efforts. The company has experienced average annual growth rates ... this growth to continue in the future as new ... , “We are very pleased that UV ...
(Date:10/1/2014)... new genetic finding from Duke Medicine suggests that some ... might also be hard-wired to gain weight when exposed ... , An estimated 13 percent of people, all of ... knowing this could help them reduce heart disease with ... stress management. , "Genetic susceptibility, psychosocial stress and metabolic ...
Breaking Medicine News(10 mins):Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2
... The following is being,issued by Center for Consumer Freedom:, ... preparing,to celebrate time-honored traditions like caroling, tree-trimming, and,leaving cookies ... of trans fat,bans and frivolous lawsuits, serving baked goods ... the receiving end of a very un-merry obesity lawsuit., ...
... Strategic ... Plan, CLEVELAND, Dec. 20 ... Executive Officer,University Hospitals, has agreed to serve as the health system,s leader for,an ... Board of Directors, said, "I join my,Board colleagues in underscoring our support for ...
... Need, NORTH KINGSTOWN, R.I., Dec. 20 On ... of Dominion Diagnostics,joined together in the spirit of the ... RI. The party proved a sight to be seen; ... Ballroom, and,many guests dressed to the nines for the ...
... PICK ONE" ENCOURAGING ... TOGETHER, NEW YORK, Dec. 20 Just in time ... launch of "Kick One, Pick One",(KOPO), the network,s new pro-social ... more time together. Bowing Jan. 1, KOPO is an,on-air, online ...
... groundbreaking experiment published in Cloning & Stem Cells, scientists ... embryonic stem cell lines that open the door for ... an immune reaction in large segments of the population. ... have a simple genetic profile in the critical areas ...
... Vegas business and Oak Ridge National Laboratory are improving the ... heart failure. , The task for ORNL researchers Chuck Britton, ... Noninvasive Medical Technologies ZOE, a medical device that monitors a ... importance to members of the military and to thousands of ...
Cached Medicine News:Health News:Center for Consumer Freedom Releases 'Don't Sue Me Santa' Christmas Cookie Liability Waiver 2Health News:University Hospitals Chief Executive Officer Extends Contract 2Health News:University Hospitals Chief Executive Officer Extends Contract 3Health News:Dominion Diagnostics Supports Rhode Island's Toys for Tots Initiative at Its 2007 Holiday Celebration 2Health News:Nick at Nite Asks Families to Kick a Bad Habit, Pick a Good One in 2008 2Health News:Nick at Nite Asks Families to Kick a Bad Habit, Pick a Good One in 2008 3Health News:Human embryonic stem cell lines created that avoid immune rejection 2Health News:Nevada company, ORNL develop potential lifesaver 2
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Medicine Products: